Attention-deficit/hyperactivity disorder medication and seizures
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Individuals with attention-deficit/hyperactivity disorder (ADHD) are at increased risk of seizures, but there is uncertainty about whether ADHD medication treatment increases risk among patients with and without preexisting seizures. METHODS: We followed a sample of 801,838 patients with ADHD who had prescribed drug claims from the Truven Health MarketScan Commercial Claims and Encounters databases to examine whether ADHD medication increases the likelihood of seizures among ADHD patients with and without a history of seizures. First, we assessed overall risk of seizures among patients with ADHD. Second, within-individual concurrent analyses assessed odds of seizure events during months when a patient with ADHD received ADHD medication compared with when the same individual did not, while adjusting for antiepileptic medications. Third, within-individual long-term analyses examined odds of seizure events in relation to the duration of months over the previous 2 years patients received medication. RESULTS: Patients with ADHD were at higher odds for any seizure compared with non-ADHD controls (odds ratio [OR] = 2.33, 95% confidence interval [CI] = 2.24-2.42 males; OR = 2.31, 95% CI = 2.22-2.42 females). In adjusted within-individual comparisons, ADHD medication was associated with lower odds of seizures among patients with (OR = 0.71, 95% CI = 0.60-0.85) and without (OR = 0.71, 95% CI = 0.62-0.82) prior seizures. Long-term within-individual comparisons suggested no evidence of an association between medication use and seizures among individuals with (OR = 0.87, 95% CI = 0.59-1.30) and without (OR = 1.01, 95% CI = 0.80-1.28) a seizure history. CONCLUSIONS: Results reaffirm that patients with ADHD are at higher risk of seizures. However, ADHD medication was associated with lower risk of seizures within individuals while they were dispensed medication, which is not consistent with the hypothesis that ADHD medication increases risk of seizures.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pliszka, S. (2007) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e318054e724 · Cited by 1,765
Logistic regression, survival analysis, and the Kaplan-Meier curve.
Efron, B. (1988) · Journal of the American Statistical Association · doi:10.1080/01621459.1988.10478612 · Cited by 1,065 · cited 2×
“We structured follow-up time by months and used discrete-time logistic regression models.(29) When new prescriptions for ADHD medication and seizures occurred in the same month (n = 100), we coded months as medicated if the seizure occurred after the date of the prescription fill (n = 51) and nonmedicated if the seizu…”
BackgroundMethodMedication for Attention Deficit–Hyperactivity Disorder and Criminality
Lichtenstein, P., Halldner, L., Zetterqvist, J., Sjölander, A., Serlachius, E., Fazel, S., Långström, N., & Larsson, H. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1203241 · Cited by 611
Self-citationChang, Z., Lichtenstein, P., D’Onofrio, B. M., Sjölander, A., & Larsson, H. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.4174 · Cited by 293
Self-citationTreatment of Attention-Deficit/Hyperactivity Disorder in Adolescents: A Systematic Review
Chan, E., Fogler, J. M., & Hammerness, P. G. (2016) · JAMA · doi:10.1001/jama.2016.5453 · Cited by 261
Stimulant ADHD medication and risk for substance abuse
Chang, Z., Lichtenstein, P., Halldner, L., D'Onofrio, B., Serlachius, E., Fazel, S., Långström, N., & Larsson, H. (2014) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.12164 · Cited by 225
Self-citationStorebø, O. J., Krogh, H. B., Ramstad, E., Moreira-Maia, C. R., Holmskov, M., Skoog, M., Nilausen, T. D., Magnusson, F. L., Zwi, M., Gillies, D., et al. (2015) · BMJ · doi:10.1136/bmj.h5203 · Cited by 209
ADHD Medication and Substance-Related Problems
Quinn, P. D., Chang, Z., Hur, K., Gibbons, R. D., Lahey, B. B., Rickert, M. E., Sjölander, A., Lichtenstein, P., Larsson, H., & D’Onofrio, B. M. (2017) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2017.16060686 · Cited by 187
Self-citationDalsgaard, S., Leckman, J. F., Mortensen, P. B., Nielsen, H. S., & Simonsen, M. (2015) · The Lancet Psychiatry · doi:10.1016/s2215-0366(15)00271-0 · Cited by 170
Childhood epilepsy, febrile seizures, and subsequent risk of ADHD
Bertelsen, E. N., Larsen, J. T., Petersen, L., Christensen, J., & Dalsgaard, S. (2016) · Pediatrics · doi:10.1542/peds.2015-4654 · Cited by 82
Cited by
Chang, Z., Ghirardi, L., Quinn, P. D., Asherson, P., D’Onofrio, B. M., & Larsson, H. (2019) · Biological Psychiatry · doi:10.1016/j.biopsych.2019.04.009 · Cited by 175
“The few available studies used a lagged approach (50, 66, 76) to test whether medication status at a given time predicted the risk of outcome a few years later.”
Self-citationCognitive disorders in epilepsy I: Clinical experience, real-world evidence and recommendations
Kanner, A. M., Helmstaedter, C., Sadat-Hossieny, Z., & Meador, K. (2020) · Seizure · doi:10.1016/j.seizure.2020.10.009 · Cited by 89
Man, K. K. C., Lau, W. C. Y., Coghill, D., Besag, F. M. C., Cross, J. H., Ip, P., & Wong, I. C. K. (2020) · The Lancet Child & Adolescent Health · doi:10.1016/s2352-4642(20)30100-0 · Cited by 68
Baby, M., Priya, V., Pallavi, J., Karthik Chand, B., Srinivasan, L., Rana, S., Tawil, S., Haque, S., Ghosh, P., Bhattacharya, P., et al. (2025) · International Journal of Women's Health · doi:10.2147/ijwh.s511297 · Cited by 2
Metadata
- Authors
- Wiggs, K. K., Chang, Z., Quinn, P. D., Hur, K., Gibbons, R., Dunn, D., Brikell, I., Larsson, H., & D'Onofrio, B. M.
- Venue
- Neurology
- Published
- 2018-03-27
- Volume
- 90
- Issue
- 13
- Pages
- e1104-e1110
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2788153005
- Cited by
- 44
- References
- 11
- FWCI
- 3.64
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Attention-deficit/hyperactivity disorder medication and seizures. https://app.cochat.ai/papers/10.1212/wnl.0000000000005213
- The paper
- Wiggs, K. K., Chang, Z., Quinn, P. D., Hur, K., Gibbons, R., Dunn, D., Brikell, I., Larsson, H., & D'Onofrio, B. M. (2018). Attention-deficit/hyperactivity disorder medication and seizures. Neurology. https://doi.org/10.1212/wnl.0000000000005213
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.